Pricing Log in Create free account

RenovoRx, Inc. (RNXT) vs Verrica Pharmaceuticals Inc. (VRCA)

RenovoRx, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. RenovoRx, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($53.7M and $53.1M). Verrica Pharmaceuticals Inc. has the higher net margin (−102.8% vs −469.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Verrica Pharmaceuticals Inc. leads on 10 and RenovoRx, Inc. on 5.

Valuation

Metric RNXT VRCA Biotechnology median
P/E n/m n/m 10.60
P/S 19.79 2.26 9.40
P/B 5.92 15.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 17.77 2.33 9.02
Earnings yield (27.19%) (51.86%) (32.88%)
Free cash flow yield (22.25%) (19.81%) (23.13%)

Profitability

Metric RNXT VRCA Biotechnology median
Gross margin 84.04% 85.89% 68.51%
Operating margin (489.05%) (93.59%) 0.00%
Net margin (469.02%) (102.84%) 0.00%
Free cash flow margin (440.38%) (44.02%) 0.00%
Return on equity (149.98%) 473.29% (51.96%)
Return on assets (110.14%) (83.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RNXT VRCA Biotechnology median
Revenue growth (TTM) — 106.21% 6.76%
EPS growth (last fiscal year) 20.00% 88.65% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RNXT VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 5.65 1.45 4.97
Net debt to EBITDA 0.56 2.59 1.01

Dividend

Metric RNXT VRCA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RNXT VRCA Biotechnology median
Market cap 53.70m 53.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack